Search Drug Registry

Medication	Therapeutic Class	Generic Mapping	Safety
V-CILLIN Comprehensive clinical and safety monograph for V-CILLIN (V-CILLIN).	Penicillin Antibiotic	V-CILLIN	caution
V-CILLIN K Comprehensive clinical and safety monograph for V-CILLIN K (V-CILLIN K).	Penicillin Antibiotic	V-CILLIN K	caution
VABOMERE Comprehensive clinical and safety monograph for VABOMERE (VABOMERE).	Carbapenem Antibiotic	VABOMERE	caution
VABYSMO Comprehensive clinical and safety monograph for VABYSMO (VABYSMO).	VEGF Inhibitor	VABYSMO	caution
VAFSEO Comprehensive clinical and safety monograph for VAFSEO (VAFSEO).	Erythropoiesis-Stimulating Agent	VAFSEO	caution
VAGIFEM Comprehensive clinical and safety monograph for VAGIFEM (VAGIFEM).	Estrogen	VAGIFEM	caution
VAGILIA Comprehensive clinical and safety monograph for VAGILIA (VAGILIA).	Probiotic	VAGILIA	caution
VAGISTAT-1 Comprehensive clinical and safety monograph for VAGISTAT-1 (VAGISTAT-1).	Azole Antifungal	VAGISTAT-1	caution
VALACYCLOVIR HYDROCHLORIDE Probenecid may decrease acyclovir clearance increasing its levels Maintain adequate hydration to prevent nephrotoxicity especially in elderly or dehydrated patients.	Antiviral	VALACYCLOVIR HYDROCHLORIDE	safe
VALBENAZINE Comprehensive clinical and safety monograph for VALBENAZINE (VALBENAZINE).	VMAT2 Inhibitor	VALBENAZINE	caution
VALBENAZINE TOSYLATE Comprehensive clinical and safety monograph for VALBENAZINE TOSYLATE (VALBENAZINE TOSYLATE).	VMAT2 Inhibitor	VALBENAZINE TOSYLATE	caution
VALCHLOR Comprehensive clinical and safety monograph for VALCHLOR (VALCHLOR).	Alkylating Agent	VALCHLOR	caution
VALCYTE Comprehensive clinical and safety monograph for VALCYTE (VALCYTE).	Antiviral Agent	VALCYTE	caution
VALGANCICLOVIR HYDROCHLORIDE Probenecid may decrease ganciclovir excretion Can cause severe myelosuppression and mutagenesis.	Antiviral	VALGANCICLOVIR HYDROCHLORIDE	avoid
VALISONE Comprehensive clinical and safety monograph for VALISONE (VALISONE).	Corticosteroid	VALISONE	caution
VALIUM Comprehensive clinical and safety monograph for VALIUM (VALIUM).	Benzodiazepine	VALIUM	caution
VALMID Comprehensive clinical and safety monograph for VALMID (VALMID).	Sedative-Hypnotic	VALMID	caution
VALNAC Comprehensive clinical and safety monograph for VALNAC (VALNAC).	Antidote	VALNAC	caution
VALPIN 50 Comprehensive clinical and safety monograph for VALPIN 50 (VALPIN 50).	Anticholinergic Agent	VALPIN 50	caution
VALPROATE SODIUM Comprehensive clinical and safety monograph for VALPROATE SODIUM (VALPROATE SODIUM).	Anticonvulsant	VALPROATE SODIUM	caution
VALPROIC ACID CYP450 enzyme inducers may decrease levels Can cause severe hepatotoxicity and teratogenic effects including neural tube defects.	Anticonvulsant	VALPROIC ACID	avoid
VALRELEASE Comprehensive clinical and safety monograph for VALRELEASE (VALRELEASE).	Anticonvulsant	VALRELEASE	caution
VALRUBICIN Comprehensive clinical and safety monograph for VALRUBICIN (VALRUBICIN).	Anthracycline Antineoplastic	VALRUBICIN	caution
VALSARTAN NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.	ARB	VALSARTAN	avoid
VALSARTAN AND HYDROCHLOROTHIAZIDE NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.	ARB	VALSARTAN AND HYDROCHLOROTHIAZIDE	avoid
VALSARTAN; HYDROCHLOROTHIAZIDE NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.	ARB	VALSARTAN; HYDROCHLOROTHIAZIDE	avoid
VALSTAR PRESERVATIVE FREE Comprehensive clinical and safety monograph for VALSTAR PRESERVATIVE FREE (VALSTAR PRESERVATIVE FREE).	Anthracycline Antineoplastic	VALSTAR PRESERVATIVE FREE	caution
VALTOCO Comprehensive clinical and safety monograph for VALTOCO (VALTOCO).	Benzodiazepine Anticonvulsant	VALTOCO	caution
VALTREX Comprehensive clinical and safety monograph for VALTREX (VALTREX).	Nucleoside Analog Antiviral	VALTREX	caution
VALTURNA Comprehensive clinical and safety monograph for VALTURNA (VALTURNA).	Antihypertensive Combination	VALTURNA	caution
VANCENASE Comprehensive clinical and safety monograph for VANCENASE (VANCENASE).	Intranasal Corticosteroid	VANCENASE	caution
VANCENASE AQ Comprehensive clinical and safety monograph for VANCENASE AQ (VANCENASE AQ).	Intranasal Corticosteroid	VANCENASE AQ	caution
VANCERIL Comprehensive clinical and safety monograph for VANCERIL (VANCERIL).	Inhaled Corticosteroid	VANCERIL	caution
VANCERIL DOUBLE STRENGTH Comprehensive clinical and safety monograph for VANCERIL DOUBLE STRENGTH (VANCERIL DOUBLE STRENGTH).	Inhaled Corticosteroid	VANCERIL DOUBLE STRENGTH	caution
VANCOCIN HYDROCHLORIDE Comprehensive clinical and safety monograph for VANCOCIN HYDROCHLORIDE (VANCOCIN HYDROCHLORIDE).	Glycopeptide Antibiotic	VANCOCIN HYDROCHLORIDE	caution
VANCOLED Comprehensive clinical and safety monograph for VANCOLED (VANCOLED).	Glycopeptide Antibiotic	VANCOLED	caution
VANCOMYCIN Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).	Glycopeptide Antibiotic	VANCOMYCIN	safe
VANCOMYCIN HCL Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).	Glycopeptide Antibiotic	VANCOMYCIN HCL	safe
VANCOMYCIN HYDROCHLORIDE Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).	Glycopeptide Antibiotic	VANCOMYCIN HYDROCHLORIDE	safe
VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).	Glycopeptide Antibiotic	VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER	safe
VANCOR Comprehensive clinical and safety monograph for VANCOR (VANCOR).	Glycopeptide Antibiotic	VANCOR	caution
VANDAZOLE Comprehensive clinical and safety monograph for VANDAZOLE (VANDAZOLE).	Nitroimidazole Antibiotic	VANDAZOLE	caution
VANFLYTA Comprehensive clinical and safety monograph for VANFLYTA (VANFLYTA).	IDH1 Inhibitor Antineoplastic	VANFLYTA	caution
VANIQA Comprehensive clinical and safety monograph for VANIQA (VANIQA).	Ornithine Decarboxylase Inhibitor	VANIQA	caution
VANOBID Comprehensive clinical and safety monograph for VANOBID (VANOBID).	Antifungal and Corticosteroid Combination	VANOBID	caution
VANOS Comprehensive clinical and safety monograph for VANOS (VANOS).	Topical Corticosteroid	VANOS	caution
VANRAFIA Comprehensive clinical and safety monograph for VANRAFIA (VANRAFIA).	Adamantane Antiviral	VANRAFIA	caution
VANSIL Comprehensive clinical and safety monograph for VANSIL (VANSIL).	Anthelmintic	VANSIL	caution
VANTAS Comprehensive clinical and safety monograph for VANTAS (VANTAS).	GnRH Agonist	VANTAS	caution
VANTIN Comprehensive clinical and safety monograph for VANTIN (VANTIN).	Cephalosporin Antibiotic	VANTIN	caution

V-CILLIN

Comprehensive clinical and safety monograph for V-CILLIN (V-CILLIN).

Penicillin Antibiotic

caution

V-CILLIN K

Comprehensive clinical and safety monograph for V-CILLIN K (V-CILLIN K).

Penicillin Antibiotic

caution

VABOMERE

Comprehensive clinical and safety monograph for VABOMERE (VABOMERE).

Carbapenem Antibiotic

caution

VABYSMO

Comprehensive clinical and safety monograph for VABYSMO (VABYSMO).

VEGF Inhibitor

caution

VAFSEO

Comprehensive clinical and safety monograph for VAFSEO (VAFSEO).

Erythropoiesis-Stimulating Agent

caution

VAGIFEM

Comprehensive clinical and safety monograph for VAGIFEM (VAGIFEM).

Estrogen

caution

VAGILIA

Comprehensive clinical and safety monograph for VAGILIA (VAGILIA).

Probiotic

caution

VAGISTAT-1

Comprehensive clinical and safety monograph for VAGISTAT-1 (VAGISTAT-1).

Azole Antifungal

caution

VALACYCLOVIR HYDROCHLORIDE

Probenecid may decrease acyclovir clearance increasing its levels Maintain adequate hydration to prevent nephrotoxicity especially in elderly or dehydrated patients.

Antiviral

safe

VALBENAZINE

Comprehensive clinical and safety monograph for VALBENAZINE (VALBENAZINE).

VMAT2 Inhibitor

caution

VALBENAZINE TOSYLATE

Comprehensive clinical and safety monograph for VALBENAZINE TOSYLATE (VALBENAZINE TOSYLATE).

VMAT2 Inhibitor

caution

VALCHLOR

Comprehensive clinical and safety monograph for VALCHLOR (VALCHLOR).

Alkylating Agent

caution

VALCYTE

Comprehensive clinical and safety monograph for VALCYTE (VALCYTE).

Antiviral Agent

caution

VALGANCICLOVIR HYDROCHLORIDE

Probenecid may decrease ganciclovir excretion Can cause severe myelosuppression and mutagenesis.

Antiviral

avoid

VALISONE

Comprehensive clinical and safety monograph for VALISONE (VALISONE).

Corticosteroid

caution

VALIUM

Comprehensive clinical and safety monograph for VALIUM (VALIUM).

Benzodiazepine

caution

VALMID

Comprehensive clinical and safety monograph for VALMID (VALMID).

Sedative-Hypnotic

caution

VALNAC

Comprehensive clinical and safety monograph for VALNAC (VALNAC).

Antidote

caution

VALPIN 50

Comprehensive clinical and safety monograph for VALPIN 50 (VALPIN 50).

Anticholinergic Agent

caution

VALPROATE SODIUM

Comprehensive clinical and safety monograph for VALPROATE SODIUM (VALPROATE SODIUM).

Anticonvulsant

caution

VALPROIC ACID

CYP450 enzyme inducers may decrease levels Can cause severe hepatotoxicity and teratogenic effects including neural tube defects.

Anticonvulsant

avoid

VALRELEASE

Comprehensive clinical and safety monograph for VALRELEASE (VALRELEASE).

Anticonvulsant

caution

VALRUBICIN

Comprehensive clinical and safety monograph for VALRUBICIN (VALRUBICIN).

Anthracycline Antineoplastic

caution

VALSARTAN

NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.

ARB

avoid

VALSARTAN AND HYDROCHLOROTHIAZIDE

NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.

ARB

avoid

VALSARTAN; HYDROCHLOROTHIAZIDE

NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Use in pregnancy can cause injury and death to the developing fetus.

ARB

avoid

VALSTAR PRESERVATIVE FREE

Comprehensive clinical and safety monograph for VALSTAR PRESERVATIVE FREE (VALSTAR PRESERVATIVE FREE).

Anthracycline Antineoplastic

caution

VALTOCO

Comprehensive clinical and safety monograph for VALTOCO (VALTOCO).

Benzodiazepine Anticonvulsant

caution

VALTREX

Comprehensive clinical and safety monograph for VALTREX (VALTREX).

Nucleoside Analog Antiviral

caution

VALTURNA

Comprehensive clinical and safety monograph for VALTURNA (VALTURNA).

Antihypertensive Combination

caution

VANCENASE

Comprehensive clinical and safety monograph for VANCENASE (VANCENASE).

Intranasal Corticosteroid

caution

VANCENASE AQ

Comprehensive clinical and safety monograph for VANCENASE AQ (VANCENASE AQ).

Intranasal Corticosteroid

caution

VANCERIL

Comprehensive clinical and safety monograph for VANCERIL (VANCERIL).

Inhaled Corticosteroid

caution

VANCERIL DOUBLE STRENGTH

Comprehensive clinical and safety monograph for VANCERIL DOUBLE STRENGTH (VANCERIL DOUBLE STRENGTH).

Inhaled Corticosteroid

caution

VANCOCIN HYDROCHLORIDE

Comprehensive clinical and safety monograph for VANCOCIN HYDROCHLORIDE (VANCOCIN HYDROCHLORIDE).

Glycopeptide Antibiotic

caution

VANCOLED

Comprehensive clinical and safety monograph for VANCOLED (VANCOLED).

Glycopeptide Antibiotic

caution

VANCOMYCIN

Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).

Glycopeptide Antibiotic

safe

VANCOMYCIN HCL

Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).

Glycopeptide Antibiotic

safe

VANCOMYCIN HYDROCHLORIDE

Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).

Glycopeptide Antibiotic

safe

VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER

Other nephrotoxic drugs increase risk of toxicity Monitor levels to minimize risk of nephrotoxicity and ototoxicity (red man syndrome).

Glycopeptide Antibiotic

safe

VANCOR

Comprehensive clinical and safety monograph for VANCOR (VANCOR).

Glycopeptide Antibiotic

caution

VANDAZOLE

Comprehensive clinical and safety monograph for VANDAZOLE (VANDAZOLE).

Nitroimidazole Antibiotic

caution

VANFLYTA

Comprehensive clinical and safety monograph for VANFLYTA (VANFLYTA).

IDH1 Inhibitor Antineoplastic

caution

VANIQA

Comprehensive clinical and safety monograph for VANIQA (VANIQA).

Ornithine Decarboxylase Inhibitor

caution

VANOBID

Comprehensive clinical and safety monograph for VANOBID (VANOBID).

Antifungal and Corticosteroid Combination

caution

VANOS

Comprehensive clinical and safety monograph for VANOS (VANOS).

Topical Corticosteroid

caution

VANRAFIA

Comprehensive clinical and safety monograph for VANRAFIA (VANRAFIA).

Adamantane Antiviral

caution

VANSIL

Comprehensive clinical and safety monograph for VANSIL (VANSIL).

Anthelmintic

caution

VANTAS

Comprehensive clinical and safety monograph for VANTAS (VANTAS).

GnRH Agonist

caution

VANTIN

Comprehensive clinical and safety monograph for VANTIN (VANTIN).

Cephalosporin Antibiotic

caution

Registry Search

Registry Search